Listed

TriSalus Life Sciences, Inc.

TLSINasdaqCIK 1826667HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$11.4m, Q2 FY2026
Operating income−$9.8m, Q2 FY2026
Net income−$9.2m, Q2 FY2026
TriSalus Life Sciences, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m5.2Revenue, Q3 FY2023, three months to 2023-09-30$5.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure5.7Revenue, Q4 FY2023, three months to 2023-12-31$5.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K/A filed 2025-05-30, accession 0001826667-25-000070. Derived: 12-month figure less the 9-month figure.Report this figure6.5Revenue, Q1 FY2024, three months to 2024-03-31$6.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure7.4Revenue, Q2 FY2024, three months to 2024-06-30$7.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure7.3Revenue, Q3 FY2024, three months to 2024-09-30$7.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure8.3Revenue, Q4 FY2024, three months to 2024-12-31$8.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure9.2Revenue, Q1 FY2025, three months to 2025-03-31$9.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure11.2Revenue, Q2 FY2025, three months to 2025-06-30$11.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure11.6Revenue, Q3 FY2025, three months to 2025-09-30$11.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure13.2Revenue, Q4 FY2025, three months to 2025-12-31$13.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure8.9Revenue, Q1 FY2026, three months to 2026-03-31$8.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure11.4Revenue, Q2 FY2026, three months to 2026-06-30$11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Cost of revenue$m0.6Cost of revenue, Q3 FY2023, three months to 2023-09-30$589.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure0.6Cost of revenue, Q4 FY2023, three months to 2023-12-31$582.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K/A filed 2025-05-30, accession 0001826667-25-000070. Derived: 12-month figure less the 9-month figure.Report this figure1.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$971.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure0.9Cost of revenue, Q2 FY2024, three months to 2024-06-30$912.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure1.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure1.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$1.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure1.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure1.8Cost of revenue, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure1.9Cost of revenue, Q3 FY2025, three months to 2025-09-30$1.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure1.8Cost of revenue, Q4 FY2025, three months to 2025-12-31$1.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure1.2Cost of revenue, Q1 FY2026, three months to 2026-03-31$1.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure1.5Cost of revenue, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Gross profit$m4.6Gross profit, Q3 FY2023, three months to 2023-09-30$4.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure5.1Gross profit, Q4 FY2023, three months to 2023-12-31$5.1m. XBRL concept us-gaap:GrossProfit. 10-K/A filed 2025-05-30, accession 0001826667-25-000070. Derived: 12-month figure less the 9-month figure.Report this figure5.5Gross profit, Q1 FY2024, three months to 2024-03-31$5.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure6.5Gross profit, Q2 FY2024, three months to 2024-06-30$6.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure6.3Gross profit, Q3 FY2024, three months to 2024-09-30$6.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure7.0Gross profit, Q4 FY2024, three months to 2024-12-31$7.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure7.7Gross profit, Q1 FY2025, three months to 2025-03-31$7.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure9.4Gross profit, Q2 FY2025, three months to 2025-06-30$9.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure9.7Gross profit, Q3 FY2025, three months to 2025-09-30$9.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure11.4Gross profit, Q4 FY2025, three months to 2025-12-31$11.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure7.7Gross profit, Q1 FY2026, three months to 2026-03-31$7.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure9.9Gross profit, Q2 FY2026, three months to 2026-06-30$9.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Research and development$m9.5Research and development, Q3 FY2023, three months to 2023-09-30$9.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure7.8Research and development, Q4 FY2023, three months to 2023-12-31$7.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2025-05-30, accession 0001826667-25-000070. Derived: 12-month figure less the 9-month figure.Report this figure5.8Research and development, Q1 FY2024, three months to 2024-03-31$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K/A filed 2025-05-30, accession 0001826667-25-000070.Report this figure4.7Research and development, Q2 FY2024, three months to 2024-06-30$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure4.2Research and development, Q3 FY2024, three months to 2024-09-30$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure3.0Research and development, Q4 FY2024, three months to 2024-12-31$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure3.0Research and development, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure3.7Research and development, Q2 FY2025, three months to 2025-06-30$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure5.2Research and development, Q3 FY2025, three months to 2025-09-30$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure2.6Research and development, Q4 FY2025, three months to 2025-12-31$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure3.2Research and development, Q1 FY2026, three months to 2026-03-31$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure3.1Research and development, Q2 FY2026, three months to 2026-06-30$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Operating income$m(18.6)Operating income, Q3 FY2023, three months to 2023-09-30−$18.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure(14.2)Operating income, Q4 FY2023, three months to 2023-12-31−$14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2025-05-30, accession 0001826667-25-000070. Derived: 12-month figure less the 9-month figure.Report this figure(11.7)Operating income, Q1 FY2024, three months to 2024-03-31−$11.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K/A filed 2025-05-30, accession 0001826667-25-000070.Report this figure(8.2)Operating income, Q2 FY2024, three months to 2024-06-30−$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure(8.7)Operating income, Q3 FY2024, three months to 2024-09-30−$8.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure(7.6)Operating income, Q4 FY2024, three months to 2024-12-31−$7.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure(7.3)Operating income, Q1 FY2025, three months to 2025-03-31−$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure(7.3)Operating income, Q2 FY2025, three months to 2025-06-30−$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure(9.0)Operating income, Q3 FY2025, three months to 2025-09-30−$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure(3.3)Operating income, Q4 FY2025, three months to 2025-12-31−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure(8.4)Operating income, Q1 FY2026, three months to 2026-03-31−$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure(9.8)Operating income, Q2 FY2026, three months to 2026-06-30−$9.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$4.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001826667-23-000007.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$3.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-04-11, accession 0001826667-24-000005. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$3.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-15, accession 0001826667-24-000017.Report this figure0.9Interest expense, Q2 FY2024, three months to 2024-06-30$877.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-14, accession 0001826667-24-000039.Report this figure1.1Interest expense, Q3 FY2024, three months to 2024-09-30$1.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure1.1Interest expense, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure1.2Interest expense, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure1.4Interest expense, Q2 FY2025, three months to 2025-06-30$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure1.5Interest expense, Q3 FY2025, three months to 2025-09-30$1.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure1.5Interest expense, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure1.4Interest expense, Q1 FY2026, three months to 2026-03-31$1.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure1.5Interest expense, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K/A filed 2025-05-30, accession 0001826667-25-000070. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure(0.0)Income tax, Q3 FY2024, three months to 2024-09-30−$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$5.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure(0.0)Income tax, Q2 FY2025, three months to 2025-06-30−$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$5.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Net income$m(1.4)Net income, Q3 FY2023, three months to 2023-09-30−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure(35.6)Net income, Q4 FY2023, three months to 2023-12-31−$35.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K/A filed 2025-05-30, accession 0001826667-25-000070. Derived: 12-month figure less the 9-month figure.Report this figure(13.2)Net income, Q1 FY2024, three months to 2024-03-31−$13.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure(4.3)Net income, Q2 FY2024, three months to 2024-06-30−$4.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure(2.4)Net income, Q3 FY2024, three months to 2024-09-30−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure(10.1)Net income, Q4 FY2024, three months to 2024-12-31−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure(10.4)Net income, Q1 FY2025, three months to 2025-03-31−$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure(8.3)Net income, Q2 FY2025, three months to 2025-06-30−$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure(10.8)Net income, Q3 FY2025, three months to 2025-09-30−$10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure(9.8)Net income, Q4 FY2025, three months to 2025-12-31−$9.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure1.5Net income, Q1 FY2026, three months to 2026-03-31$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure(9.2)Net income, Q2 FY2026, three months to 2026-06-30−$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Diluted EPS$ per share(0.14)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figurenot reported(0.60)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K/A filed 2025-05-30, accession 0001826667-25-000070.Report this figure(0.21)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure(0.12)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figurenot reported(0.39)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure(0.27)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure(0.96)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figurenot reported0.03Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure(0.16)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Basic EPS$ per share(0.14)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figurenot reported(0.60)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K/A filed 2025-05-30, accession 0001826667-25-000070.Report this figure(0.21)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure(0.12)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figurenot reported(0.39)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure(0.27)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure(0.96)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figurenot reported0.03Basic EPS, Q1 FY2026, three months to 2026-03-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure(0.16)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure

Balance sheet

Cash and equivalents$46.3m, Q2 FY2026
Long-term debt$33.1m, Q2 FY2026
Shareholders' equity$6.5m, Q2 FY2026
TriSalus Life Sciences, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m21.4Cash and equivalents, Q3 FY2023, at 2023-09-30$21.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001826667-23-000007.Report this figure11.8Cash and equivalents, FY2023, at 2023-12-31$11.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K/A filed 2025-05-30, accession 0001826667-25-000070.Report this figure4.0Cash and equivalents, Q1 FY2024, at 2024-03-31$4.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001826667-24-000017.Report this figure16.5Cash and equivalents, Q2 FY2024, at 2024-06-30$16.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001826667-24-000039.Report this figure11.3Cash and equivalents, Q3 FY2024, at 2024-09-30$11.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure8.5Cash and equivalents, FY2024, at 2024-12-31$8.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001628280-26-015163.Report this figure13.0Cash and equivalents, Q1 FY2025, at 2025-03-31$13.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure26.5Cash and equivalents, Q2 FY2025, at 2025-06-30$26.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure22.7Cash and equivalents, Q3 FY2025, at 2025-09-30$22.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure20.4Cash and equivalents, FY2025, at 2025-12-31$20.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure56.6Cash and equivalents, Q1 FY2026, at 2026-03-31$56.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure46.3Cash and equivalents, Q2 FY2026, at 2026-06-30$46.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Current assets$m29.0Current assets, Q3 FY2023, at 2023-09-30$29.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001826667-23-000007.Report this figure20.9Current assets, FY2023, at 2023-12-31$20.9m. XBRL concept us-gaap:AssetsCurrent. 10-K/A filed 2025-05-30, accession 0001826667-25-000070.Report this figure13.2Current assets, Q1 FY2024, at 2024-03-31$13.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001826667-24-000017.Report this figure27.9Current assets, Q2 FY2024, at 2024-06-30$27.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001826667-24-000039.Report this figure23.8Current assets, Q3 FY2024, at 2024-09-30$23.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure20.7Current assets, FY2024, at 2024-12-31$20.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001628280-26-015163.Report this figure25.1Current assets, Q1 FY2025, at 2025-03-31$25.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure38.1Current assets, Q2 FY2025, at 2025-06-30$38.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure33.3Current assets, Q3 FY2025, at 2025-09-30$33.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure32.2Current assets, FY2025, at 2025-12-31$32.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure68.1Current assets, Q1 FY2026, at 2026-03-31$68.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure59.7Current assets, Q2 FY2026, at 2026-06-30$59.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Total assets$m33.6Total assets, Q3 FY2023, at 2023-09-30$33.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001826667-23-000007.Report this figure24.6Total assets, FY2023, at 2023-12-31$24.6m. XBRL concept us-gaap:Assets. 10-K/A filed 2025-05-30, accession 0001826667-25-000070.Report this figure17.9Total assets, Q1 FY2024, at 2024-03-31$17.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001826667-24-000017.Report this figure32.4Total assets, Q2 FY2024, at 2024-06-30$32.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001826667-24-000039.Report this figure27.5Total assets, Q3 FY2024, at 2024-09-30$27.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure24.0Total assets, FY2024, at 2024-12-31$24.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001628280-26-015163.Report this figure28.6Total assets, Q1 FY2025, at 2025-03-31$28.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure41.3Total assets, Q2 FY2025, at 2025-06-30$41.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure36.5Total assets, Q3 FY2025, at 2025-09-30$36.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure35.3Total assets, FY2025, at 2025-12-31$35.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure71.0Total assets, Q1 FY2026, at 2026-03-31$71.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure62.4Total assets, Q2 FY2026, at 2026-06-30$62.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Current liabilities$m9.3Current liabilities, Q3 FY2023, at 2023-09-30$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001826667-23-000007.Report this figure14.7Current liabilities, FY2023, at 2023-12-31$14.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K/A filed 2025-05-30, accession 0001826667-25-000070.Report this figure14.4Current liabilities, Q1 FY2024, at 2024-03-31$14.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001826667-24-000017.Report this figure12.0Current liabilities, Q2 FY2024, at 2024-06-30$12.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001826667-24-000039.Report this figure9.9Current liabilities, Q3 FY2024, at 2024-09-30$9.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure10.2Current liabilities, FY2024, at 2024-12-31$10.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001628280-26-015163.Report this figure11.8Current liabilities, Q1 FY2025, at 2025-03-31$11.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure9.3Current liabilities, Q2 FY2025, at 2025-06-30$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure10.9Current liabilities, Q3 FY2025, at 2025-09-30$10.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure11.5Current liabilities, FY2025, at 2025-12-31$11.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure11.8Current liabilities, Q1 FY2026, at 2026-03-31$11.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure11.2Current liabilities, Q2 FY2026, at 2026-06-30$11.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Total liabilities$m25.1Total liabilities, Q3 FY2023, at 2023-09-30$25.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001826667-23-000007.Report this figure51.7Total liabilities, FY2023, at 2023-12-31$51.7m. XBRL concept us-gaap:Liabilities. 10-K/A filed 2025-05-30, accession 0001826667-25-000070.Report this figure52.8Total liabilities, Q1 FY2024, at 2024-03-31$52.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001826667-24-000017.Report this figure56.6Total liabilities, Q2 FY2024, at 2024-06-30$56.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001826667-24-000039.Report this figure47.9Total liabilities, Q3 FY2024, at 2024-09-30$47.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure49.9Total liabilities, FY2024, at 2024-12-31$49.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001628280-26-015163.Report this figure63.0Total liabilities, Q1 FY2025, at 2025-03-31$63.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure60.7Total liabilities, Q2 FY2025, at 2025-06-30$60.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure63.2Total liabilities, Q3 FY2025, at 2025-09-30$63.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure69.2Total liabilities, FY2025, at 2025-12-31$69.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure58.2Total liabilities, Q1 FY2026, at 2026-03-31$58.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure55.9Total liabilities, Q2 FY2026, at 2026-06-30$55.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Long-term debt$mnot reported0.0Long-term debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K/A filed 2025-05-30, accession 0001826667-25-000070.Report this figurenot reported21.3Long-term debt, Q2 FY2024, at 2024-06-30$21.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-14, accession 0001826667-24-000039.Report this figure21.7Long-term debt, Q3 FY2024, at 2024-09-30$21.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure22.1Long-term debt, FY2024, at 2024-12-31$22.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-05, accession 0001628280-26-015163.Report this figure31.7Long-term debt, Q1 FY2025, at 2025-03-31$31.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure32.3Long-term debt, Q2 FY2025, at 2025-06-30$32.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure32.8Long-term debt, Q3 FY2025, at 2025-09-30$32.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure33.0Long-term debt, FY2025, at 2025-12-31$33.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure33.1Long-term debt, Q1 FY2026, at 2026-03-31$33.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure33.1Long-term debt, Q2 FY2026, at 2026-06-30$33.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure
Shareholders' equity$m8.3Shareholders' equity, Q3 FY2023, at 2023-09-30$8.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure(27.1)Shareholders' equity, FY2023, at 2023-12-31−$27.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001628280-26-015163.Report this figure(36.0)Shareholders' equity, Q1 FY2024, at 2024-03-31−$36.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure(25.3)Shareholders' equity, Q2 FY2024, at 2024-06-30−$25.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure(20.4)Shareholders' equity, Q3 FY2024, at 2024-09-30−$20.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure(25.9)Shareholders' equity, FY2024, at 2024-12-31−$25.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure(34.4)Shareholders' equity, Q1 FY2025, at 2025-03-31−$34.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure(19.4)Shareholders' equity, Q2 FY2025, at 2025-06-30−$19.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure(26.7)Shareholders' equity, Q3 FY2025, at 2025-09-30−$26.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure(33.9)Shareholders' equity, FY2025, at 2025-12-31−$33.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure12.8Shareholders' equity, Q1 FY2026, at 2026-03-31$12.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure6.6Shareholders' equity, Q2 FY2026, at 2026-06-30$6.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure

Cash flow

Operating cash flow−$10.1m, Q2 FY2026
Capital expenditure$82.0k, Q2 FY2026
TriSalus Life Sciences, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(21.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$21.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001826667-24-000051. Derived: 9-month figure less the 6-month figure.Report this figure(9.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2025-05-30, accession 0001826667-25-000070. Derived: 12-month figure less the 9-month figure.Report this figure(10.9)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$10.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K/A filed 2025-05-30, accession 0001826667-25-000070.Report this figure(13.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$13.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001826667-25-000117. Derived: 6-month figure less the 3-month figure.Report this figure(10.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$10.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001628280-25-052043. Derived: 9-month figure less the 6-month figure.Report this figure(5.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure(4.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure(7.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054275. Derived: 6-month figure less the 3-month figure.Report this figure(3.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001628280-25-052043. Derived: 9-month figure less the 6-month figure.Report this figure(2.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure(6.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure(10.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$10.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054275. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$178.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001826667-24-000051. Derived: 9-month figure less the 6-month figure.Report this figure0.4Capital expenditure, Q4 FY2023, three months to 2023-12-31$372.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K/A filed 2025-05-30, accession 0001826667-25-000070. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$66.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$60.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001826667-25-000117. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$169.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001628280-25-052043. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$50.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q1 FY2025, three months to 2025-03-31$754.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure(0.1)Capital expenditure, Q2 FY2025, three months to 2025-06-30−$93.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054275. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2025, three months to 2025-09-30$216.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001628280-25-052043. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$41.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001628280-26-015163. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$141.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$82.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054275. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)58.30m, Q2 FY2026
TriSalus Life Sciences, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30311,823 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001826667-23-000007.Report this figure16.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3116,166,581 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001826667-24-000017.Report this figure0.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30446,287 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001826667-24-000039.Report this figure13.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3013,173,422 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001826667-24-000051.Report this figure23.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3123,323,045 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001826667-25-000051.Report this figure23.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3023,903,659 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001826667-25-000117.Report this figure26.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3026,501,597 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure28.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3128,527,453 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure32.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3032,899,297 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure43.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3043,057,632 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001628280-25-052043.Report this figure52.3Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3152,314,410 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001628280-26-034100.Report this figure58.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3058,296,711 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure

Shares outstanding: 61.57mShares outstanding, period not labelled, at 2026-08-0461,574,600 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628280-26-054275.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.